David Buck
Research management professional with over 20 years of experience in creating leading and coaching teams of outstanding molecular biologists. This experience has been gained in results-driven environments that have involved complex restructuring, international expansion and implementation of cutting edge technology in the area of DNA sequencing and genetic analysis. Recognised and accomplished leader with a track record and execution skills that have engendered improved scientific performance, heightened productivity and enhanced internal controls. Strong interpersonal qualities and the desire and skill set needed to succeed in the fast moving, competitive sphere of High Throughput Genomics.
Recent publications
-
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Working paper
Ahern DJ. et al, (2021)
-
Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cells
Journal article
Lines KE. et al, (2020), Endocrine-Related Cancer, 27, 163 - 174
-
Sequencing of human genomes with nanopore technology
Journal article
Bowden R. et al, (2019), Nature Communications, 10
-
A practical solution for preserving single cells for RNA sequencing
Journal article
Attar M. et al, (2018), Scientific Reports, 8
-
Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls
Journal article
Flannick J. et al, (2018), Scientific Data, 5